BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 8653285)

  • 1. Significance of placental alkaline phosphatase (PLAP) in the monitoring of patients with seminoma.
    Koshida K; Uchibayashi T; Yamamoto H; Hirano K
    Br J Urol; 1996 Jan; 77(1):138-42. PubMed ID: 8653285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Human placental alkaline phosphatase (hPLAP) is the most frequently elevated serum marker in testicular cancer].
    Neumann A; Keller T; Jocham D; Doehn C
    Aktuelle Urol; 2011 Sep; 42(5):311-5. PubMed ID: 21809268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of alkaline phosphatase isoenzymes as tumor markers for testicular germ cell tumors.
    Koshida K; Nishino A; Yamamoto H; Uchibayashi T; Naito K; Hisazumi H; Hirano K; Hayashi Y; Wahren B; Andersson L
    J Urol; 1991 Jul; 146(1):57-60. PubMed ID: 1711586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An assessment of combined tumour markers in patients with seminoma: placental alkaline phosphatase (PLAP), lactate dehydrogenase (LD) and beta human chorionic gonadotrophin (beta HCG).
    Munro AJ; Nielsen OS; Duncan W; Sturgeon J; Gospodarowicz MK; Malkin A; Thomas GM; Jewett MA
    Br J Cancer; 1991 Sep; 64(3):537-42. PubMed ID: 1716953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of tumor markers in testicular seminomas. Results of a prospective multicenter study.
    Weissbach L; Bussar-Maatz R; Mann K
    Eur Urol; 1997; 32(1):16-22. PubMed ID: 9266226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The search for biomarkers of metastatic seminoma.
    Ruf CG; Khalili-Harbi N; Sachs S; Isbarn H; Wagner W; Matthies C; Meineke V; Fisch M; Chun FK; Abend M
    J Urol; 2013 Sep; 190(3):1046-51. PubMed ID: 23583226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placental alkaline phosphatase as a tumor marker for seminoma.
    Lange PH; Millan JL; Stigbrand T; Vessella RL; Ruoslahti E; Fishman WH
    Cancer Res; 1982 Aug; 42(8):3244-7. PubMed ID: 7093962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tumor markers in testicular cancer].
    Mann K
    Urologe A; 1990 Mar; 29(2):77-86. PubMed ID: 2158684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum and tissue tumour markers in seminomas.
    Ford TF; Butcher DN; Samuell CT; Masters JR; Parkinson MC; Oliver RT
    Br J Urol; 1985 Dec; 57(6):750-4. PubMed ID: 2417651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring of seminoma patients with serum markers.
    Hotakainen K; Lempiäinen A; Stenman UH
    Cancer; 2013 Jul; 119(13):2511. PubMed ID: 23584987
    [No Abstract]   [Full Text] [Related]  

  • 11. Reply to Monitoring of seminoma patients with serum markers.
    Vesprini D; Warde P; Chung P
    Cancer; 2013 Jul; 119(13):2511-2. PubMed ID: 23584974
    [No Abstract]   [Full Text] [Related]  

  • 12. Diagnostic markers for germ cell neoplasms: from placental-like alkaline phosphatase to micro-RNAs.
    Rajpert-De Meyts E; Nielsen JE; Skakkebaek NE; Almstrup K
    Folia Histochem Cytobiol; 2015; 53(3):177-88. PubMed ID: 26306513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of seminoma tissue markers and deletions.
    Yamamoto H; Rudén U; Ljungdahl-Ståhle E; Brehmer-Andersson E; Hirano K; Hisazumi H; Stigbrand T; Wahren B
    Int J Cancer; 1987 Nov; 40(5):615-9. PubMed ID: 2445700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of markers M2A, OCT3/4, AP-2gamma, PLAP and c-KIT in the detection of extragonadal seminomas.
    Biermann K; Klingmüller D; Koch A; Pietsch T; Schorle H; Büttner R; Zhou H
    Histopathology; 2006 Sep; 49(3):290-7. PubMed ID: 16918976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Tumour Markers in Testicular Germ Cell Tumours: Frequencies of Elevated Levels and Extents of Marker Elevation Are Significantly Associated with Clinical Parameters and with Response to Treatment.
    Dieckmann KP; Simonsen-Richter H; Kulejewski M; Anheuser P; Zecha H; Isbarn H; Pichlmeier U
    Biomed Res Int; 2019; 2019():5030349. PubMed ID: 31275973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profiles of epitope-defined markers in sera from patients with testicular germ cell tumors.
    Yamamoto H; Rudén U; Esposti P; Hirano K; Stigbrand T; Andersson L; Hisazumi H; Wahren B
    Urol Res; 1988; 16(1):31-6. PubMed ID: 2449757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of serum tumor markers during surveillance for stage I seminoma.
    Vesprini D; Chung P; Tolan S; Gospodarowicz M; Jewett M; O'Malley M; Sweet J; Moore M; Panzarella T; Sturgeon J; Sugar L; Anson-Cartwright L; Warde P
    Cancer; 2012 Nov; 118(21):5245-50. PubMed ID: 22517478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum and tissue levels of placental alkaline phosphatase in patients with testicular tumor].
    Nishino A; Koshida K; Yamamoto H; Uchibayashi T; Naito K; Hisazumi H; Hirano K; Hayashi K
    Nihon Hinyokika Gakkai Zasshi; 1990 Oct; 81(10):1506-12. PubMed ID: 2273701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis of primary testicular seminoma: a report on 57 new cases.
    Fujikawa K; Matsui Y; Oka H; Fukuzawa S; Sasaki M; Takeuchi H
    Cancer Res; 2000 Apr; 60(8):2152-4. PubMed ID: 10786678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum and tissue levels of manganese superoxide dismutase in testicular germ cell tumors.
    Koshida K; Adachi T; Yamamoto H; Uchibayashi T; Hirano K
    Eur Urol; 1996; 29(4):487-90. PubMed ID: 8791060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.